The FDA has paused its pub­lic re­lease of phar­ma re­jec­tion let­ters as the agency seeks to avoid lit­i­ga­tion around re­leas­ing the of­ten sen­si­tive in­for­ma­tion.

The...

Plus, news about RoslinCT, No­vo Nordisk and more.  

🇬🇧 Catal­ent to sell UK site to Codis: The CD­MO is set to takeCatal­ent’s oral sol­id...

There's an an­swer emerg­ing on the multi­bil­lion-dol­lar ques­tion of whether the Trump ad­min­is­tra­tion's gut­ting of FDA staff in April 2025 would slow down drug ap­provals...

Bio­phar­ma's M&A en­gine is revved up and shows no signs of cool­ing off.

Four com­pa­nies have an­nounced ac­qui­si­tions in the first six days of Ju­ly...

San­doz un­veiled a di­rect-to-con­sumer plat­form, start­ing off with a sin­gle med­ica­tion for now as the gener­ic drug­mak­er adopts a sys­tem that sev­er­al brand-name man­u­fac­tur­ers are...